4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-009870
Options or other derivatives
- Chief Scientific Officer acquired 300,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| ROBINS HARLAN S Chief Scientific Officer | 2020-02-13 | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…